NCT03424070 is a NA clinical trial of Shoulder Roll in Intubation;Difficult, sponsored by State University of New York at Buffalo.

Who is sponsoring NCT03424070?

NCT03424070 is sponsored by State University of New York at Buffalo.

What drugs are being tested in NCT03424070?

Interventions in NCT03424070: Shoulder Roll, No shoulder roll (placebo).

What condition does NCT03424070 study?

NCT03424070 studies Intubation;Difficult.

Is NCT03424070 still recruiting?

NCT03424070 is currently completed. Last updated 15 May 2018.

Last reviewed 2018-05-15 · How we verify

NCT03424070

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glottic View in Infants With a Shoulder Roll

Completed NA Last updated 15 May 2018

What this trial tests

NA trial testing Shoulder Roll in Intubation;Difficult in 20 participants. Completed in 5 May 2018.

Timeline

18 February 2018

Primary endpoint
5 May 2018

5 May 2018

Quick facts

Lead sponsor	State University of New York at Buffalo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	other
Enrollment	20
Start date	18 February 2018
Primary completion	5 May 2018
Estimated completion	5 May 2018
Sites	1 location across United States

Drugs / interventions tested

Shoulder Roll
No shoulder roll (placebo)

Conditions studied

Intubation;Difficult — all drugs for Intubation;Difficult →

Sponsor

State University of New York at Buffalo

Who can join

Adults 1 Day to 1, any sex, with Intubation;Difficult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the distance from the operating table to the eye of the laryngoscopist while intubating the trachea with or without a shoulder roll. A photo of the glottic opening will compare the glottic views in both positions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other State University of New York at Buffalo trials

Trials by the same sponsor.

NCT07072767 — Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation · NA · not yet recruiting
NCT07140848 — CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes · NA · not yet recruiting
NCT07433959 — Neuromodulation to Improve Grasping Function After SCI · NA · not yet recruiting
NCT07403539 — Speech Learning and Speech Production in Parkinson's Disease · NA · recruiting
NCT05367362 — Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute · Phase 2 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03424070 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by State University of New York at Buffalo
Last refreshed: 15 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03424070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing